JUNUTULA; Jagath R.
Patent Applications and Registrations
Patent applications and USPTO patent grants for JUNUTULA; Jagath R..The latest application filed is for "antibodies that bind to lrp6 proteins and methods of use".
Company Profile
7.20.27
- JUNUTULA; Jagath R. - Fremont CA
- Junutula; Jagath R - South San Francisco CA
- - Fremont CA US
- Junutula; Jagath R. - St. Fremont CA
Patent Activity
| Patent | Date |
|---|---|
| Antibodies That Bind To Lrp6 Proteins And Methods Of Use App 20220281969 - SIDHU; Sachdev S. ; et al. | 2022-09-08 |
| Anti-IL1-RAP antibodies Grant 11,359,025 - Jiang , et al. June 14, 2 | 2022-06-14 |
| Humanized anti-CLL-1 antibodies Grant 11,072,662 - Jiang , et al. July 27, 2 | 2021-07-27 |
| Isoquinolidinobenzodiazepines Grant 10,898,580 - Junutula , et al. January 26, 2 | 2021-01-26 |
| Cysteine Engineered Antibodies and Conjugates App 20200339664 - Bhakta; Sunil ; et al. | 2020-10-29 |
| Cysteine engineered antibodies and conjugates Grant 10,604,557 - Bhakta , et al. | 2020-03-31 |
| Isoquinolidinobenzodiazepine (iqb)-1(chloromethyl)-2,3-dihydro-1h-benzo[e]indole (cbi) Dimers App 20200061079 - JUNUTULA; Jagath R. ; et al. | 2020-02-27 |
| Cysteine Engineered Antibodies And Conjugates App 20200017601 - BHAKTA; Sunil ; et al. | 2020-01-16 |
| Anti-il1-rap Antibodies App 20190338038 - Jiang; Ying Ping ; et al. | 2019-11-07 |
| Isoquinolidinobenzodiazepine (IQB)-1(chloromethyl)-2,3-dihydro-1H-benzo[e]indole (CBI) dimers Grant 10,350,218 - Junutula , et al. July 16, 2 | 2019-07-16 |
| Cysteine engineered anti-MUC16 antibodies and antibody drug conjugates Grant RE47,194 - Junutula , et al. J | 2019-01-08 |
| Humanized Anti-cll-1 Antibodies App 20180355044 - Jiang; Ying-Ping ; et al. | 2018-12-13 |
| Cysteine-substituted Immunoglobulins App 20180312592 - JUNUTULA; Jagath R. ; et al. | 2018-11-01 |
| Isoquinolidinobenzodiazepines App 20180280529 - Junutula; Jagath R. ; et al. | 2018-10-04 |
| Cysteine engineered antibodies and conjugates Grant 10,077,318 - Bhakta , et al. September 18, 2 | 2018-09-18 |
| Isoquinolidinobenzodiazepine (iqb)-1(chloromethyl)-2,3-dihydro-1h-benzo[e]indole (cbi) Dimers App 20180177795 - JUNUTULA; Jagath R. ; et al. | 2018-06-28 |
| Isoquinolidinobenzodiazepines Grant 9,974,864 - Junutula , et al. May 22, 2 | 2018-05-22 |
| Cysteine Engineered Antibodies And Conjugates App 20170260253 - Bhakta; Sunil ; et al. | 2017-09-14 |
| Isoquinolidinobenzodiazepines App 20170157265 - JUNUTULA; Jagath R. ; et al. | 2017-06-08 |
| Compositions And Methods For The Diagnosis And Treatment Of Tumor App 20170129963 - Bhakta; Sunil ; et al. | 2017-05-11 |
| Compositions and methods for the diagnosis and treatment of tumor Grant 9,580,514 - Bhakta , et al. February 28, 2 | 2017-02-28 |
| Isoquinolidinobenzodiazepines Grant 9,504,694 - Junutula , et al. November 29, 2 | 2016-11-29 |
| Isoquinolidinobenzodiazepines App 20160271142 - JUNUTULA; JAGATH R. ; et al. | 2016-09-22 |
| Anti-FcRH5 antibodies and immunoconjugates and methods of use Grant 9,360,484 - Elkins , et al. June 7, 2 | 2016-06-07 |
| Cysteine Engineered Antibodies And Conjugates App 20160130358 - BHAKTA; Sunil ; et al. | 2016-05-12 |
| Anti-FcRH5 antibodies and immunoconjugates and methods of use Grant 9,017,951 - Elkins , et al. April 28, 2 | 2015-04-28 |
| Compositions And Methods For The Diagnosis And Treatment Of Tumor App 20150098946 - Bhakta; Sunil ; et al. | 2015-04-09 |
| Cysteine engineered antibodies and conjugates Grant 9,000,130 - Bhakta , et al. April 7, 2 | 2015-04-07 |
| Zirconium-radiolabeled, Cysteine Engineered Antibody Conjugates App 20150017094 - Gill; Herman ; et al. | 2015-01-15 |
| Cysteine Engineered Antibodies And Conjugates App 20140288280 - Bhakta; Sunil ; et al. | 2014-09-25 |
| ANTI-FcRH5 ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE App 20140106374 - Elkins; Kristi ; et al. | 2014-04-17 |
| Anti-FcRH5 antibodies and immunoconjugates and methods of use Grant 08617559 - | 2013-12-31 |
| Anti-FcRH5 antibodies and immunoconjugates and methods of use Grant 8,617,559 - Elkins , et al. December 31, 2 | 2013-12-31 |
| Anti-FcRH5 antibodies and immunoconjugates and methods of use Grant 8,466,260 - Elkins , et al. June 18, 2 | 2013-06-18 |
| ANTI-FcRH5 ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE App 20130089497 - Elkins; Kristi ; et al. | 2013-04-11 |
| ANTI-FcRH5 ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE App 20130089555 - Elkins; Kristi ; et al. | 2013-04-11 |
| Compositions And Methods For The Diagnosis And Treatment Of Tumor App 20130058960 - Bhakta; Sunil ; et al. | 2013-03-07 |
| Anti-FcRH5 antibodies and immunoconjugates and methods of use Grant 8,362,213 - Elkins , et al. January 29, 2 | 2013-01-29 |
| Alaninyl Maytansinol Antibody Conjugates App 20120121615 - Flygare; John A. ; et al. | 2012-05-17 |
| Cysteine Engineered Antibodies And Conjugates App 20110301334 - Bhakta; Sunil ; et al. | 2011-12-08 |
| ANTI-FcRH5 ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE App 20110171125 - Elkins; Kristi ; et al. | 2011-07-14 |
| ANTI-FcRH5 ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE App 20100260748 - Elkins; Kristi ; et al. | 2010-10-14 |
| Cysteine engineered anti-MUC16 antibodies and antibody drug conjugates Grant 7,723,485 - Junutula , et al. May 25, 2 | 2010-05-25 |
| Zirconium-radiolabeled, Cysteine Engineered Antibody Conjugates App 20100111856 - Gill; Herman ; et al. | 2010-05-06 |
| Cysteine Engineered Anti-muc16 Antibodies And Antibody Drug Conjugates App 20080311134 - Junutula; Jagath R. ; et al. | 2008-12-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 